‘How Do You Decide?’: Cancer Treatment’s CAR-T Crisis Has Patients Dying on a Wait List

The shortage of CAR-T therapy for multiple myeloma is creating a gut-wrenching dilemma for clinicians — one that they must debate each week at CAR-T myeloma programs like Yi Lin’s at the Mayo Clinic.